Medicare Enrolled
Dr. Glenn Bloiso, MD
Urology Physician · Williamsport, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bloiso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bloiso?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bloiso
Dr. Glenn Bloiso is an urology physician in Williamsport, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bloiso performed 7,557 Medicare services across 1,399 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bloiso received a total of $2,312 from 29 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bloiso is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in PA
$2,312 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,557
Medicare services
Top 6% in PA for urology physician
1,399
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~398 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,283 | $2 | $7 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
2,200 | $5 | $13 |
| Denosumab injection (Prolia/Xgeva) | 1,020 | $19 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
803 | $91 | $237 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
200 | $7 | $40 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
194 | $176 | $449 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 186 | $136 | $1,162 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $62 | $159 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
111 | $117 | $350 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
58 | $65 | $242 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
35 | $43 | $182 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
33 | $49 | $183 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
30 | $25 | $69 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $43 | $95 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
28 | $102 | $383 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
25 | $60 | $155 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
24 | $16 | $58 |
| Insertion of temporary bladder tube | 23 | $34 | $119 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
22 | $424 | $1,262 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
22 | $311 | $971 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
21 | $228 | $535 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $39 | $95 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $10 | $58 |
| Injection of implant material into bladder or urethra A procedure where implant material is injected beneath the lining of the bladder and/or urethra using an endoscope. |
15 | $129 | $444 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
12 | $100 | $291 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $25 | $202 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
46.4% medium
52.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,312
Total received (2018-2024)
Avg $385/year across 6 years
Top 49% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,247 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$686
2023
$456
2022
$541
2021
$386
2019
$59
2018
$184
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$133
PFIZER INC.
$91
Boston Scientific Corporation
$64
Merck Sharp & Dohme LLC
$53
C. R. Bard, Inc. & Subsidiaries
$47
COLOPLAST CORP
$45
Ferring Pharmaceuticals Inc.
$44
Janssen Biotech, Inc.
$42
PROCEPT BioRobotics Corporation
$41
ABBVIE INC.
$41
Myriad Genetic Laboratories, Inc.
$29
BIOPROTECT MEDICAL, INC.
$19
Teleflex LLC
$19
Tempus AI, Inc
$18
Top 3 companies account for 42.0% of 2024 payments
All-time payments by company (2018-2024) ›
Axonics, Inc.
$345
Astellas Pharma US Inc
$289
Sumitomo Pharma America, Inc.
$169
AbbVie Inc.
$155
United Medical Systems (DE), Inc.
$153
ABBVIE INC.
$152
PFIZER INC.
$143
Merck Sharp & Dohme Corporation
$85
Janssen Biotech, Inc.
$71
Teleflex LLC
$71
Boston Scientific Corporation
$64
UROVANT SCIENCES INC
$64
Ferring Pharmaceuticals Inc.
$57
COLOPLAST CORP
$56
UroGen Pharma, Inc.
$56
Merck Sharp & Dohme LLC
$53
Allergan, Inc.
$51
C. R. Bard, Inc. & Subsidiaries
$47
PROCEPT BioRobotics Corporation
$41
Myriad Genetic Laboratories, Inc.
$29
ConvaTec Inc.
$28
Antares Pharma, Inc.
$20
BIOPROTECT MEDICAL, INC.
$19
Tempus AI, Inc
$18
Photocure Inc
$17
Endo Pharmaceuticals Inc.
$17
Coloplast Corp
$15
Allergan Inc.
$13
UROGEN PHARMA, INC.
$13
Top 3 companies account for 34.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM SYSTEM · Axonics · Axonics r-SNM System · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · Bard Urinary Drainage Bag · Bulkamid · Cysview · ERLEADA · FIRMAGON · GEMTESA · GENTLECATH · JELMYTO · KEYTRUDA · LUPRON DEPOT · Luja Coude · MYRBETRIQ · NOCDURNA · ORGOVYX · PROLARIS · Porges Coloplast · Solyx SIS System · SpeediCath · UROLIFT · XIAFLEX · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
4
Per 100K population
3.5
County median income
$64,412
Nearest hospital
UPMC WILLIAMSPORT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bloiso is a mixed practice specialist, with above-average Medicare volume (top 6% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bloiso experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Bloiso performed 2,283 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bloiso receive payments from pharmaceutical companies?
Yes. Dr. Bloiso received a total of $2,312 from 29 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bloiso's costs compare to other urology physicians in Williamsport?
Dr. Bloiso's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bloiso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Williamsport
Browse urology physicians in Williamsport ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology